Ketek Superiority Trials May Hold Key To Sales After Safety Relabeling

Sanofi-Aventis recently conducted superiority trials for its antibiotic Ketek, and the results could determine whether the drug bounces back from an FDA decision to withdraw two indications from the drug's label